483 Debut Development Sep 2018

483 Debut Development Sep 2018

Jennifer Lalama FDA$119.00 - Available Now

FDA investigators audited the Debut Development - Wauchula, FL, United States facility and issued inspectional observations (via FDA 483) on 20 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Sep 2018
  • Location: Wauchula, United States
  • FEI: 3011505385
Add To Cart